OpenURL Connection Search

Select item for more details and to access through your institution.

Resected pancreatic adenocarcinoma: An Asian institution's experience.
Published in:
Cancer Reports, 2021, v. 4, n. 5, p. 1, doi. 10.1002/cnr2.1393
By:
- Ng, Kennedy Yao Yi;
- Chow, Edwin Wei Xiang;
- Jiang, Bochao;
- Lim, Cindy;
- Goh, Brian Kim Poh;
- Lee, Ser Yee;
- Teo, Jin Yao;
- Tan, Damien Meng Yew;
- Cheow, Peng Chung;
- Ooi, London Lucien Peng Jin;
- Chow, Pierce Kah Hoe;
- Lee, Joycelyn Jie Xin;
- Kam, Juinn Huar;
- Koh, Ye Xin;
- Jeyaraj, Prema Raj;
- Tan, Ek Khoon;
- Choo, Su Pin;
- Chan, Chung Yip;
- Chung, Alexander Yaw Fui;
- Tai, David
Publication type:
Article
Immune checkpoint inhibitors and tyrosine kinase inhibitors in patients with advanced hepatocellular carcinoma: Does the sequence matter?
Published in:
Asia Pacific Journal of Clinical Oncology, 2023, v. 19, n. 3, p. 312, doi. 10.1111/ajco.13837
By:
- Ng, Kennedy Yao Yi;
- Wong, Lawrence Wen Jun;
- Ang, Andrea Jing Shi;
- Lee, Ailica Wan Xin;
- Tay, Desiree Shu Hui;
- Tan, Jack Jie En;
- Tan, Sze Huey;
- Choo, Su Pin;
- Tai, David Wai‐Meng;
- Lee, Joycelyn Jie Xin
Publication type:
Article
Real‐world efficacy and safety of immune checkpoint inhibitors in advanced hepatocellular carcinoma: Experience of a tertiary Asian Center.
Published in:
Asia Pacific Journal of Clinical Oncology, 2021, v. 17, n. 5, p. e249, doi. 10.1111/ajco.13454
By:
- Ng, Kennedy Yao Yi;
- Wong, Lawrence Wen Jun;
- Ang, Andrea Jing Shi;
- Tan, Sze Huey;
- Choo, Su Pin;
- Tai, David Wai‐Meng;
- Lee, Joycelyn Jie Xin
Publication type:
Article
First-Line Systemic Therapies for Advanced Hepatocellular Carcinoma: A Systematic Review and Patient-Level Network Meta-Analysis.
Published in:
Liver Cancer (2235-1795), 2023, v. 12, n. 1, p. 7, doi. 10.1159/000526639
By:
- Fong, Khi Yung;
- Zhao, Joseph Jonathan;
- Sultana, Rehena;
- Lee, Joycelyn Jie Xin;
- Lee, Suat Ying;
- Chan, Stephen Lam;
- Yau, Thomas;
- Tai, David Wai Meng;
- Sundar, Raghav;
- Too, Chow Wei
Publication type:
Article
Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma.
Published in:
Liver Cancer (2235-1795), 2022, v. 11, n. 1, p. 9, doi. 10.1159/000518619
By:
- Ng, Kennedy Yao Yi;
- Tan, Sze Huey;
- Tan, Jack Jie En;
- Tay, Desiree Shu Hui;
- Lee, Ailica Wan Xin;
- Ang, Andrea Jing Shi;
- Wong, Lawrence Wen Jun;
- Choo, Su Pin;
- Tai, David Wai-Meng;
- Lee, Joycelyn Jie Xin
Publication type:
Article
Immunohistochemical scoring of LAG-3 in conjunction with CD8 in the tumor microenvironment predicts response to immunotherapy in hepatocellular carcinoma.
Published in:
Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1150985
By:
- Chun Chau Cheung, Lawrence;
- Justin Seah, Yong Hock;
- Juntao Fang;
- Calpatura Orpilla, Nicole Hyacinth;
- Mai Chan Lau;
- Chun Jye Lim;
- Xinru Lim;
- Li Wen Lee, Justina Nadia;
- Chun Tatt Lim, Jeffrey;
- Lim, Sherlly;
- Qing Cheng;
- Han Chong Toh;
- Su Pin Choo;
- Suat Ying Lee;
- Jie Xin Lee, Joycelyn;
- Jin Liu;
- Kiat Hon Lim, Tony;
- Tai, David;
- Yeong, Joe
Publication type:
Article

Found: 6

Resected pancreatic adenocarcinoma: An Asian institution's experience.

Immune checkpoint inhibitors and tyrosine kinase inhibitors in patients with advanced hepatocellular carcinoma: Does the sequence matter?

Real‐world efficacy and safety of immune checkpoint inhibitors in advanced hepatocellular carcinoma: Experience of a tertiary Asian Center.

First-Line Systemic Therapies for Advanced Hepatocellular Carcinoma: A Systematic Review and Patient-Level Network Meta-Analysis.

Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma.

Immunohistochemical scoring of LAG-3 in conjunction with CD8 in the tumor microenvironment predicts response to immunotherapy in hepatocellular carcinoma.